Melief CJ - Search Results

1

Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody.

Fransen MF, Sluijter M, Morreau H, Arens R, Melief CJ. Fransen MF, et al. Among authors: melief cj. Clin Cancer Res. 2011 Apr 15;17(8):2270-80. doi: 10.1158/1078-0432.CCR-10-2888. Epub 2011 Mar 9. Clin Cancer Res. 2011. PMID: 21389097

2

Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope.

Ressing ME, van Driel WJ, Celis E, Sette A, Brandt MP, Hartman M, Anholts JD, Schreuder GM, ter Harmsel WB, Fleuren GJ, Trimbos BJ, Kast WM, Melief CJ. Ressing ME, et al. Among authors: melief cj. Cancer Res. 1996 Feb 1;56(3):582-8. Cancer Res. 1996. PMID: 8564975

3

Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hosts.

Toes RE, Kast WM, Blom RJ, Bakker SC, Offringa R, Melief CJ. Toes RE, et al. Among authors: melief cj. Int J Cancer. 1996 May 29;66(5):686-91. doi: 10.1002/(SICI)1097-0215(19960529)66:5<686::AID-IJC17>3.0.CO;2-2. Int J Cancer. 1996. PMID: 8647633 Free article.

4

Protective antitumor immunity induced by immunization with completely allogeneic tumor cells.

Toes RE, Blom RJ, van der Voort E, Offringa R, Melief CJ, Kast WM. Toes RE, et al. Among authors: melief cj. Cancer Res. 1996 Aug 15;56(16):3782-7. Cancer Res. 1996. PMID: 8706024

5

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

Vierboom MP, Nijman HW, Offringa R, van der Voort EI, van Hall T, van den Broek L, Fleuren GJ, Kenemans P, Kast WM, Melief CJ. Vierboom MP, et al. Among authors: melief cj. J Exp Med. 1997 Aug 29;186(5):695-704. doi: 10.1084/jem.186.5.695. J Exp Med. 1997. PMID: 9271585 Free PMC article.

6

Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product.

Visseren MJ, van der Burg SH, van der Voort EI, Brandt RM, Schrier PI, van der Bruggen P, Boon T, Melief CJ, Kast WM. Visseren MJ, et al. Among authors: melief cj. Int J Cancer. 1997 Sep 26;73(1):125-30. doi: 10.1002/(sici)1097-0215(19970926)73:1<125::aid-ijc19>3.0.co;2-f. Int J Cancer. 1997. PMID: 9334819 Free article.

7

Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells.

De Bruijn ML, Schuurhuis DH, Vierboom MP, Vermeulen H, de Cock KA, Ooms ME, Ressing ME, Toebes M, Franken KL, Drijfhout JW, Ottenhoff TH, Offringa R, Melief CJ. De Bruijn ML, et al. Among authors: melief cj. Cancer Res. 1998 Feb 15;58(4):724-31. Cancer Res. 1998. PMID: 9485027

8

Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells.

Toes RE, van der Voort EI, Schoenberger SP, Drijfhout JW, van Bloois L, Storm G, Kast WM, Offringa R, Melief CJ. Toes RE, et al. Among authors: melief cj. J Immunol. 1998 May 1;160(9):4449-56. J Immunol. 1998. PMID: 9574550

9

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. Schoenberger SP, et al. Among authors: melief cj. Nature. 1998 Jun 4;393(6684):480-3. doi: 10.1038/31002. Nature. 1998. PMID: 9624005

10

Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopes.

van Hall T, van de Rhee NE, Schoenberger SP, Vierboom MP, Verreck FA, Melief CJ, Offringa R. van Hall T, et al. Among authors: melief cj. Cancer Res. 1998 Jul 15;58(14):3087-93. Cancer Res. 1998. PMID: 9679975

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

543 results

Search Page